Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2012
03/06/2012CA2486055C Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
03/06/2012CA2483707C Microparticles bearing cells and active substances
03/06/2012CA2452881C Novel bicyclic and tricyclic cannabinoids
03/06/2012CA2442694C Osteoprotegerin in milk
03/06/2012CA2392880C Compositions comprising neisseria meningitidis antigens from serogroups b and c
03/06/2012CA2370697C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
03/06/2012CA2202408C Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
03/01/2012WO2012027570A2 Dual variable domain immunoglobulins and uses thereof
03/01/2012WO2012027365A2 Targeted multi-epitope dosage forms for induction of an immune response to antigens
03/01/2012WO2012027017A2 Novel agonists of toll-like receptor 3 and methods of their use
03/01/2012WO2012026712A2 Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing stem cells treated with nod2 agonist or cultured product thereof
03/01/2012WO2012026309A1 Creation of anti-pad4 antibody pharmaceutical
03/01/2012WO2012025473A1 Cc.chemokine receptor 4 antagonists
03/01/2012WO2012024817A1 Whole egg protein peptides, preparation method and use thereof
03/01/2012WO2011139986A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
03/01/2012US20120053509 Vaccines for human papilloma virus and methods for using the same
03/01/2012US20120053451 Methods and systems for prolonged localization of drug delivery
03/01/2012US20120053240 Method of Administering beta-hydroxy-beta-methylbutyrate (HMB)
03/01/2012US20120053235 Dihydromyricetin as an IKK-beta inhibitor used for treatment of arthritis, cancer and autoimmune conditions, and other diseases or disorders
03/01/2012US20120053232 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN TUMOR SUPPRESSING SUBTRANSFERABLE CANDIDATE 4 (TSSC4)
03/01/2012US20120053228 Splice-region antisense composition and method
03/01/2012US20120053214 The little molecule compound which used for promoting the stem cells hyperplasia and the use thereof
03/01/2012US20120053210 Compounds that modulate intracellular calcium
03/01/2012US20120053199 Noscapine and analogs and methods related thereto
03/01/2012US20120053198 Water-soluble solid pharmaceutical inclusion complexes and their aqueous solutions for oral, ophthalmic, topical or parenteral use containing a macrolide and certain cyclodextrins
03/01/2012US20120053189 Btk inhibitors for the treatment of immune mediated conditions
03/01/2012US20120053187 Tri-cyclic pyrazolopyridine kinase inhibitors
03/01/2012US20120053186 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
03/01/2012US20120053184 Salts of 3-(1h-ind0l-3-yl)-4-[2-(4-methyl-piperazin-i-yl)-quinazolin-4-yl]-pyrrole-2, 5-di one
03/01/2012US20120053178 3-(1,2,3-Triazol-4-yl) pyrrolo [2,3-b] pyridine derivatives
03/01/2012US20120053174 Quinazoline compounds and methods of use thereof
03/01/2012US20120053167 Triazine Derivatives as Kinase Inhibitors
03/01/2012US20120053166 4-Oxadiazol-2-YL-Indazoles as Inhibitors of P13 Kinases
03/01/2012US20120053164 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
03/01/2012US20120053159 Isotopologues of lenalidomide
03/01/2012US20120053147 Thiazolopyrimidinone derivatives as pi3 kinase inhibitors
03/01/2012US20120053129 Target-activated cell/tissue-penetrating peptide for delivery of impermeable compounds and use thereof
03/01/2012US20120052132 Compositions and methods for treatment of body weight conditions
03/01/2012US20120052116 Immunogenic epitopes of ngep antigen
03/01/2012US20120052097 Therapeutic peptide-polymer conjugates, particles, compositions, and related methods
03/01/2012US20120052095 Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
03/01/2012US20120052094 Agonists of Neurotrophin Receptors and Their Use as Medicaments
03/01/2012US20120052092 Vaccine compositions comprising a mutated factor h binding protein
03/01/2012US20120052090 Peptidic antigen that induces antibody recognizing three-dimensional structure of hiv and method for synthesizing same
03/01/2012US20120052089 Newcastle disease virus vectored herpesvirus vaccines
03/01/2012US20120052087 Siderophore Conjugate Immunogenic Compositions and Vaccines
03/01/2012US20120052086 Vaccine composition for prophylaxis and/or therapy of alzheimer's disease
03/01/2012US20120052085 Vaccines against tularemia
03/01/2012US20120052084 Staphylococcus aureus proteins and nucleic acids
03/01/2012US20120052083 MUTANT CyaA POLYPEPTIDES AND POLYPEPTIDE DERIVATIVES SUITABLE FOR THE DELIVERY OF IMMUNOGENIC MOLECULES INTO A CELL
03/01/2012US20120052082 Cross-protective influenza vaccine
03/01/2012US20120052081 Compositions for use in the treatment of chronic obstructive pulmonary diseases and asthma
03/01/2012US20120052077 Therapeutic modulation of vaginal epithelium boundary lubrication
03/01/2012US20120052072 High affinity human antibodies to human il-4 receptor
03/01/2012US20120052068 Autophilic antibodies and method of making the same
03/01/2012US20120052066 Markers and methods for assessing and treating lupus patients susceptible to photoprovocation
03/01/2012US20120052060 Human Antibody Molecules For IL-13
03/01/2012US20120052059 Regulatory b cells and their use
03/01/2012US20120052050 Use of specific lactic bacteria for the preparation of immunomodulating compositions
03/01/2012US20120052044 Uses of mammalian cytokine; related reagents
03/01/2012US20120052019 Certain chemical entities, compositions, and methods
03/01/2012US20120052007 Peripheral blood sparc binding antibodies and uses thereof
03/01/2012US20120052005 Combination therapy to improve drug efficiency
03/01/2012CA2809029A1 Targeted multi-epitope dosage forms for induction of an immune response to antigens
03/01/2012CA2802721A1 Novel agonists of toll-like receptor 3 and methods of their use
02/2012
02/29/2012EP2423335A2 Chimeric immunomodulatory compounds and methods of using the same
02/29/2012EP2423228A1 Antibody containing igg2 having amino acid mutation introduced therein
02/29/2012EP2423190A1 Compounds Exhibiting PGD 2 Receptor Antagonism
02/29/2012EP2422813A1 Agent for regulating composition ratio of intestinal bacterial flora
02/29/2012EP2422769A1 Compositions and methods for improved organ transplant preservation and acceptance
02/29/2012EP2421877A1 Anionic conjugates of glycosylated bacterial metabolite
02/29/2012EP2421867A2 Piperidine inhibitors of janus kinase 3
02/29/2012EP2421846A1 5-alkynyl-pyridines
02/29/2012EP2421844A1 Thiophene inhibitors of ikk-b serine-threonine protein kinase
02/29/2012EP2421552A1 Compositions for use in the treatment of chronic obstructive pulmonary diseases and asthma
02/29/2012EP2421536A1 Methods of treatment for solid tumors
02/29/2012EP2421505A2 Hydrogels for combinatorial delivery of immune-modulating biomolecules
02/29/2012EP2123649B1 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof
02/29/2012EP1625850B1 Immunostimulating agents
02/29/2012EP1622860B1 AMINO-PROPANOL DERIVATIVES AS SPHINGOSINE-1-PHOSPHATE RECEPTOR MODULATORs
02/29/2012EP1311269B1 Method of using diketopiperazines and composition containing them
02/29/2012CN1947747B Traditional Chinese medicine composition containing luteolin and capsule of sweeping forsythia and its preparation method and use
02/29/2012CN102365086A Composition for alleviating ultraviolet radiation-induced damage
02/29/2012CN102363784A Ruditapes philippinarum Defensin B gene, its recombinant protein and application
02/29/2012CN102363783A Venerupis philippinarum defensin A gene, and recombinant protein and application thereof
02/29/2012CN102363036A Chinese medicinal composition for clearing throat and pharynx, and preparation method thereof
02/29/2012CN102363007A Chinese medicinal formula and method for treating spleen channel and lung channel complicating disease
02/29/2012CN102363006A Formula of Chinese medicines and method for treating combined spleen channel and heart channel tissue diseases
02/29/2012CN102363004A Chinese medicinal formula and method for treating kidney channel and spleen channel complicating disease
02/29/2012CN102362992A Chinese medicinal composition for treating dermatomyositis
02/29/2012CN102362980A Chinese medicinal formula and method for treating spleen channel and heart channel complicating disease
02/29/2012CN102362972A Chinese medicine for treating dermatomyositis
02/29/2012CN102362961A Traditional Chinese medicinal formula for treating dermatomyositis
02/29/2012CN102362957A Chinese patent medicine for treating deep lupus erythematosus
02/29/2012CN102133305B Health-care products or medicines composition used for improving immunity and preventing 'three high' and application thereof
02/29/2012CN102018680B Emedastine difumarate sustained release tablets and preparation method thereof
02/29/2012CN101926950B Brain-invigorating traditional Chinese medicine composite and preparation method and detection method thereof
02/29/2012CN101780119B Cordyceps militaris and Agaricus blazei medicated wine and preparation method thereof
02/29/2012CN101708178B Compound sustained-release tablet of cetirizine and pseudoephedrine and preparation method thereof
02/29/2012CN101628903B Defervescence anti-inflammatory and anti-infection medicine with immunization function, preparation and application thereof
1 ... 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 ... 1172